Clinical Effects of the Prostaglandins on the Respiratory System

  • Maurice F. Cuthbert
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 13)


The prostaglandins were first isolated from the lungs by Bergström and his coworkers more than 14 years ago (1). It is now established that in animal studies all prostaglandins have powerful effects on both respiratory smooth muscle and on pulmonary vascular smooth muscle and that the lungs have an important function in their metabolic degradation, since some 90–95% of infused E and F prostaglandins are removed predominantly by the enzyme 15-prostaglandin dehydrogenase (15-PGDH) on a single passage through the pulmonary circulation. It is of interest that the A prostaglandins, which have a similar but less potent effect than the E prostaglandins, are less readily degraded by 15-PGDH in the lungs of experimental animals. Similar results have been obtained with prostaglandin F (PGF) man and it is suggested that degradation occurs in the pulmonary endothelial cells (2,3).


Airway Resistance Bronchodilator Effect Flufenamic Acid Disodium Cromoglycate Pulmonary Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    BERGSTROM S et al (1962) The isolation and structure of a smooth-muscle stimulating factor in normal pig and sheep lungs, Arkiv fur Kemi 20 63Google Scholar
  2. 2.
    PIPER P J, VANE J R & WYLLIE J H (1970) Inactivation of prostaglandins by the lung. Nature (Lond) 225 600CrossRefGoogle Scholar
  3. 3.
    JOSE P, NIEDERHAUSER U, PIPER P J, ROBINSON C & SMITH P A (1976) Inactivation of prostaglandin F2a in the human pulmonary circulation. British Journal of Clinical Pharmacology 3, 342Google Scholar
  4. 4.
    SWEATMAN W J F & COLLIER HOJ (1968) Effects of prostaglandins on human bronchial muscle. Nature (Lond) 217 69CrossRefGoogle Scholar
  5. 4a.
    GARDINER P J (1975) The effects of some natural prostaglandins on isolated human circular bronchial muscle. Prostaglandins 10 607PubMedCrossRefGoogle Scholar
  6. 5.
    LARGE B J, LESWELL P F & MAXWELL D R (1969) Bronchodilator activity of prostaglandin E-| in experimental animals. Nature (Lond) 224 78CrossRefGoogle Scholar
  7. 6.
    ROSENTHALE M E, DERVINIS A & GLUCKMAN J (1973) Comparative studies on the bronchodilating properties of prostaglandin F2b. Advances in Biosciences 9 229Google Scholar
  8. 7.
    CUTHBERT M F (1969) Effect on airways resistance of prostaglandin E1 given by aerosol to healthy and asthmatic volunteers, British Medical Journal 4, 723PubMedCrossRefGoogle Scholar
  9. 8.
    HERXHEIMER H & ROETSCHER I (1971) Effects of prostaglandin E-J on lung function in bronchial asthma, European Journal of Clinical Pharmacology 3 123CrossRefGoogle Scholar
  10. 9.
    MATHE A A, HEDQVIST P, HOLMGREN A & SVANBORG N (1973) Bronchial hyperreactivity to prostaglandin F2a and histamine in patients with asthma. British Medical Journal 1 193PubMedCrossRefGoogle Scholar
  11. 10.
    SMITH A P & CUTHBERT M F (1972) The antagonistic action of prostaglandins F2a and E2 aerosols on bronchial muscle tone in man, British Medical Journal 2 212CrossRefGoogle Scholar
  12. 11.
    SMITH A P, CUTHBERT M F & DUNLOP L S (1975) Effects of inhaled prostaglandins E1, E2 and F2a on the airway resistance of healthy and asthmatic man. Clinical Science 48, 421Google Scholar
  13. 12.
    HEDQVIST P, HOLMGREN A & MATHÉ A A (1971) Effect of prostaglandin F2a on airways resistance in man, Acta Physiologica Scand 82, 29aCrossRefGoogle Scholar
  14. 13.
    SMITH A P (1973) The effects of intravenous infusion of graded doses of prostaglandins F2a and E2 on lung resistance in patients undergoing termination of pregnancy. Clinical Science 44 17PubMedGoogle Scholar
  15. 14.
    FISHBURNE J I, BRENNER W E, BRAAKSMA J T, STAUROVSKY L G, MUELLER R A, HOFFER J L & HENDRICKS C H (1972) Cardiovascular and respiratory responses to intravenous PGF2a in the pregnant woman. Obstetrics & Gynecology 39 892Google Scholar
  16. 15.
    CARLSON L A, EKELUND L & ORO L (1969) Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiologica Scand 75 161CrossRefGoogle Scholar
  17. 16.
    NAKANO J & COLE B (1969) Effects of prostaglandins E1 and F2a on systemic, pulmonary and splanchnic circulations in dogs. American Journal of Physiology 217 222PubMedGoogle Scholar
  18. 17.
    NAKANO J & KESSINGER J M (1970) Effects of 8-iso PGE1 on the systemic and pulmonary circulations in dogs. Proceedings of the Society for Experimental Biology & Medicine 133 1314Google Scholar
  19. 18.
    DUCHARME D W & WEEKS J R (1967) Cardiovascular pharmacology of PGF2a, a unique pressor agent. Proceedings of the Nobel Symposium 2 ‘Prostaglandins’ Bergstrom S & Samuelsson B Eds. Interscience New York p 173Google Scholar
  20. 19.
    SAID S I (1968) Some respiratory effects of prostaglandins E2 and F2a. Prostaglandin Symposium of the Worcest er Foundation. Ramwell P W & Shaw J E. Eds Interscience New York p 207Google Scholar
  21. 20.
    ÄNGGARD E (1965) The isolation and determination of prostaglandins in lungs of sheep, guinea pig, monkey and man. Biochemical Pharmacology 14 1507PubMedCrossRefGoogle Scholar
  22. 21.
    KARIM S M M, SANDLER M & WILLIAMS E D (1967) Distribution of prostaglandins in human tissues. British Journal of Pharmacology 31 340Google Scholar
  23. 22.
    PIPER P J & VANE J R (1971) The release of prostaglandins from lung and other tissues. Annals of the New York Academy of Sciences, 180 363PubMedCrossRefGoogle Scholar
  24. 23.
    CLARKE S W, GRAF P D & NADEL J A (1970) The in vivo visualisation of small-airway constriction after pulmonary microembolism in cats and dogs. Journal of Applied Physiology 29 646PubMedGoogle Scholar
  25. 24.
    VANE J R (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology 231 646Google Scholar
  26. 25.
    FARMER J B, FARRAR D G & WILSON J (1974) The effect of indomethacin on the tracheal smooth muscle of the guinea pig. British Journal of Pharmacology 52 559PubMedGoogle Scholar
  27. 26.
    DUNLOP L S & SMITH A P (1975) Reduction of antigen-induced contraction of sensitised human bronchus in vitro by indomethacin, British Journal of Pharmacology 54 495PubMedGoogle Scholar
  28. 27.
    SMITH A P (1975) Effect of indomethacin in asthma: Evidence against a role for prostaglandins in its pathogenesis, British Journal of Clinical Pharmacology 2 307PubMedGoogle Scholar
  29. 28.
    SAMUELSSON B (1973) Quantitative aspects of prostaglandin synthesis in man. Advances in Biosciences, International Conference on Prostaglandins, Bergstrom S Ed. 9 7Google Scholar
  30. 29.
    NEMOTO T, KONDO T & TOSHIO I (1976) Serum prostaglandin levels in asthmatic patients. Journal of Allergy and Clinical Immunology 57 89PubMedCrossRefGoogle Scholar
  31. 30.
    GREEN K, HEDQVIST P &. SVANBORG N (1974) Increased plasma levels of 15-keto-13,14-dihydro-prostaglandin F2a after allergen-provoked asthma in man. Lancet 2 1419PubMedCrossRefGoogle Scholar
  32. 31.
    MATHÉ A A, STRANDBERG K & ASTROM A (1971) Blockade by polyphloretin phosphate of the prostaglandin Fga action on isolated human bronchi. Nature New Biology 230 215PubMedCrossRefGoogle Scholar
  33. 12a.
    PATEL K R (1976) Effect of prostaglandin F2 alpha on lung mechanics in extrinsic asthma. Postgraduate Medical Journal 52 275PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • Maurice F. Cuthbert
    • 1
    • 2
  1. 1.Department of Pharmacology & TherapeuticsLondon Hospital Medical CollegeLondon E 1England
  2. 2.Chest Unit, Department of MedicineKings College HospitalLondon S E 5England

Personalised recommendations